Literature DB >> 21824204

Pituitary adenylate cyclase-activating polypeptide controls stimulus-transcription coupling in the hypothalamic-pituitary-adrenal axis to mediate sustained hormone secretion during stress.

N Stroth1, Y Liu, G Aguilera, L E Eiden.   

Abstract

External and internal stimuli that threaten homeostasis trigger coordinated stress responses through activation of specialised neuroendocrine circuits. In mammals, the hypothalamic-pituitary-adrenal (HPA) axis mediates responses to stressors such as restraint, ultimately enhancing adrenocortical hormone secretion. Pituitary adenylate cyclase-activating polypeptide (PACAP) has been implicated in central control of the HPA axis, and we have recently shown PACAP-dependent expression of corticotropin-releasing hormone (CRH) and secretion of corticosterone in response to restraint. We now provide a more detailed analysis of PACAP-dependent HPA axis stimulation in the mouse, indicating that the hypothalamic paraventricular nucleus (PVN) is the primary site of action. We demonstrate by quantitative polymerase chain reaction and in situ hybridisation that up-regulation of mRNAs encoding CRH and inducible transcription factors, from the Nr4a family (Nur77, Nor1) in the PVN is PACAP-dependent. Furthermore, CRH hnRNA is rapidly up-regulated in cultured hypothalamic neurones after treatment with PACAP. Induction of Nr4a factors (Nur77, Nurr1) in response to restraint is attenuated in the pituitary gland of PACAP-deficient mice. In the adrenal glands, restraint elicits a marked PACAP-dependent increase in adrenocortical mRNA levels of all three Nr4a transcription factors, steroidogenic factor 1 (Nr5a1), steroidogenic acute regulatory protein and steroid 21-hydroxylase. Taken together, our results show that PACAP controls HPA responses to restraint primarily at the level of the hypothalamus by up-regulating CRH, possibly involving transcription factors such as Nur77 and Nor1. Subsequent adrenocortical steroidogenesis also appears to involve PACAP-dependent stimulus-transcription coupling, suggesting a mechanism by which PACAP exerts control over HPA axis function during stress.
© 2011 The Authors. Journal of Neuroendocrinology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824204      PMCID: PMC3183119          DOI: 10.1111/j.1365-2826.2011.02202.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  39 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Antagonism between Nur77 and glucocorticoid receptor for control of transcription.

Authors:  A Philips; M Maira; A Mullick; M Chamberland; S Lesage; P Hugo; J Drouin
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.

Authors:  Christine Martens; Steve Bilodeau; Mario Maira; Yves Gauthier; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2004-12-09

4.  Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus.

Authors:  V Grinevich; A Fournier; G Pelletier
Journal:  Brain Res       Date:  1997-10-31       Impact factor: 3.252

5.  Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.

Authors:  M Maira; C Martens; A Philips; J Drouin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

6.  Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo.

Authors:  Lee E Eiden; Babru Samal; Matthew J Gerdin; Tomris Mustafa; David Vaudry; Nikolas Stroth
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus.

Authors:  D Parkes; S Rivest; S Lee; C Rivier; W Vale
Journal:  Mol Endocrinol       Date:  1993-10

8.  Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.

Authors:  Damián Kovalovsky; Damián Refojo; Ana Clara Liberman; Daniel Hochbaum; Marcelo Paez Pereda; Omar A Coso; Günter K Stalla; Florian Holsboer; Eduardo Arzt
Journal:  Mol Endocrinol       Date:  2002-07

9.  Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons.

Authors:  K J Kovács; P E Sawchenko
Journal:  J Neurosci       Date:  1996-01       Impact factor: 6.167

10.  The NR4A subgroup: immediate early response genes with pleiotropic physiological roles.

Authors:  Megan A Maxwell; George E O Muscat
Journal:  Nucl Recept Signal       Date:  2006-02-08
View more
  31 in total

1.  Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor.

Authors:  Andrew C Emery; Lee E Eiden
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

Review 2.  Is PACAP the major neurotransmitter for stress transduction at the adrenomedullary synapse?

Authors:  Corey B Smith; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2012-05-18       Impact factor: 3.444

3.  Rapgef2 connects GPCR-mediated cAMP signals to ERK activation in neuronal and endocrine cells.

Authors:  Andrew C Emery; Maribeth V Eiden; Tomris Mustafa; Lee E Eiden
Journal:  Sci Signal       Date:  2013-06-25       Impact factor: 8.192

4.  Pituitary adenylate cyclase-activating polypeptide (PACAP) in the bed nucleus of the stria terminalis (BNST) increases corticosterone in male and female rats.

Authors:  K R Lezak; E Roelke; O M Harris; I Choi; S Edwards; N Gick; G Cocchiaro; G Missig; C W Roman; K M Braas; D J Toufexis; V May; S E Hammack
Journal:  Psychoneuroendocrinology       Date:  2014-03-25       Impact factor: 4.905

5.  Impact of PACAP and PAC1 receptor deficiency on the neurochemical and behavioral effects of acute and chronic restraint stress in male C57BL/6 mice.

Authors:  Tomris Mustafa; Sunny Zhihong Jiang; Adrian M Eiden; Eberhard Weihe; Ian Thistlethwaite; Lee E Eiden
Journal:  Stress       Date:  2015-09-04       Impact factor: 3.493

Review 6.  PACAP: A regulator of mammalian reproductive function.

Authors:  Stephen J Winters; Joseph P Moore
Journal:  Mol Cell Endocrinol       Date:  2020-06-17       Impact factor: 4.102

7.  PACAP controls adrenomedullary catecholamine secretion and expression of catecholamine biosynthetic enzymes at high splanchnic nerve firing rates characteristic of stress transduction in male mice.

Authors:  N Stroth; B A Kuri; T Mustafa; S-A Chan; C B Smith; L E Eiden
Journal:  Endocrinology       Date:  2012-12-07       Impact factor: 4.736

8.  PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress.

Authors:  Michael L Lehmann; Tomris Mustafa; Adrian M Eiden; Miles Herkenham; Lee E Eiden
Journal:  Psychoneuroendocrinology       Date:  2012-10-11       Impact factor: 4.905

9.  Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches.

Authors:  Claude Robert; Laurence Bourgeais; Charles-Daniel Arreto; Miguel Condes-Lara; Rodrigo Noseda; Thérèse Jay; Luis Villanueva
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

10.  Discrete signal transduction pathway utilization by a neuropeptide (PACAP) and a cytokine (TNF-alpha) first messenger in chromaffin cells, inferred from coupled transcriptome-promoter analysis of regulated gene cohorts.

Authors:  Babru Samal; Djida Ait-Ali; Stephen Bunn; Tomris Mustafa; Lee E Eiden
Journal:  Peptides       Date:  2013-04-19       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.